Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors

Area of Science:

• Pharmacology
• Neuroscience
• Computational Chemistry

Background:

• Alpha2-adrenergic receptors (α2Rs), specifically α2A (α2AR) and α2C (α2CR) subtypes, are crucial for physiological processes but poorly understood.
• Existing drug discovery for α2Rs is hindered by high binding pocket homology between α2AR and α2CR, complicating selective targeting.
• Differential signaling of α2AR (beneficial) and α2CR (potentially detrimental) necessitates subtype-specific modulators.

Purpose of the Study:

• To discover novel chemotypes with selective pharmacological profiles at α2AR and α2CR.
• To investigate a new class of compounds, 5-substituted-2-aminotetralins (5-SATs), for their potential as selective α2R modulators.
• To elucidate the molecular mechanisms underlying the distinct functional activities of 5-SAT analogues at α2AR and α2CR.

Main Methods:

• Synthesis and pharmacological evaluation of novel 5-substituted-2-aminotetralin (5-SAT) analogues.
• In vitro assessment of ligand affinity and functional activity (Gαi-mediated inhibition of adenylyl cyclase and cAMP production).
• Molecular modeling, including molecular dynamics (MD) simulations and docking, of α2AR and α2CR with a lead compound (FPT) and lofexidine.

Main Results:

• Identified 5-SAT analogues exhibiting a novel pharmacological profile: partial agonists at α2AR and inverse agonists at α2CR.
• Demonstrated high potency (EC50 < 2 nM) for lead compounds at both α2AR and α2CR.
• Computational analysis revealed specific amino acid interactions of the lead compound FPT with α2AR and α2CR, potentially explaining its multifaceted activity.

Conclusions:

• The novel 5-SAT chemotype offers a promising scaffold for developing subtype-selective α2R modulators.
• The identified partial agonism at α2AR and inverse agonism at α2CR represent a unique therapeutic approach.
• Integrated computational and experimental data provide insights into ligand-induced stabilization of distinct GPCR conformations for α2AR and α2CR.